Contemporary management of infrapopliteal peripheral arterial disease

Angiology

Volumn 62, Issue 6, 2011, Pages 490-499

  Falluji, Nezar ^a   Mukherjee, Debabrata ^b  

^a St Joseph Heart Institute   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

angioplasty; atherectomy; contrast nephropathy; infrapopliteal stenosis; peripheral arterial disease; peripheral stenting

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; CLOPIDOGREL; CYPHER; HEPARIN; HIRULOG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PACLITAXEL; RAPAMYCIN; TAXAN; UNCLASSIFIED DRUG; WARFARIN;

AIR EMBOLISM; ANTICOAGULANT THERAPY; ARTERY DISSECTION; ARTERY EMBOLISM; ARTERY PERFORATION; ARTERY SPASM; ARTERY THROMBOSIS; ARTICLE; ATHERECTOMY; BARE METAL STENT; BYPASS SURGERY; COHORT ANALYSIS; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTRAST INDUCED NEPHROPATHY; CRITICAL LIMB ISCHEMIA; DIRECTIONAL ATHERECTOMY; DRUG ELUTING STENT; EXCIMER LASER; EXCISIONAL ATHERECTOMY; GUIDE WIRE; HEALTH CARE ACCESS; HEMATOMA; HIGH RISK PATIENT; HUMAN; INFRAPOPLIETAL PERIPHERAL ARTERIAL DISEASE; INFRAPOPLITEAL PERIPHERAL ARTERIAL DISEASE; INTERMETHOD COMPARISON; LASER ATHERE; LASER ATHERECTOMY; LASER SURGERY; LEG REVASCULARIZATION; LIFESTYLE MODIFICATION; LIMB ISCHEMIA; ORBITAL ATHERECTOMY; PATHOPHYSIOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL ARTERY; RESTENOSIS; ROTATIONAL ATHERECTOMY; SMOKING CESSATION;

ENDOVASCULAR PROCEDURES; HUMANS; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; STENTS; VASCULAR SURGICAL PROCEDURES;

EID: 79960955814     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319710398011     Document Type: Article

References (56)

1. Paraskevas KI, Kotsikoris I., Koupidis SA, Giannoukas AD, Mikhailidis DP Ankle-brachial index: a marker of both peripheral arterial disease and systemic atherosclerosis as well as a predictor of vascular events. Angiology. 2010 ; 61 (6). 521-523.
2. Tziomalos K., Athyros VG, Karagiannis A., Mikhailidis DP The role of ankle brachial index and carotid intima-media thickness in vascular risk stratification. Curr Opin Cardiol. 2010 ; 25 (4). 394-398.
3. Carmona GA, Hoffmeyer P., Herrmann FR, et al. Major lower limb amputations in the elderly observed over ten years: the role of diabetes and peripheral arterial disease. Diabetes Metab. 2005 ; 31 (5). 449-454. (Pubitemid 41639967)
4. Robless P., Mikhailidis DP, Stansby GP Cilostazol for peripheral arterial disease. Cochrane Database Syst Rev. 2008 ; 1: CD003748.
5. Menard MT, Belkin M. Infrapopliteal intervention for the treatment of the claudicant. Semin Vasc Surg. 2007 ; 20 (1). 42-53. (Pubitemid 46453131)
6. Norgren L., Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007 ; 33 (suppl 1). S1 - S75.
7. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol. 2006 ; 47 (6). 1239-1312.
8. Karnabatidis D., Katsanos K., Siablis D. Infrapopliteal stents: overview and unresolved issues. J Endovasc Ther. 2009 ; 16 (suppl1). 1153-1162.
9. Donaldson MC, Mannick JA, Whittemore AD Femoral-distal bypass with in situ greater saphenous vein. Long-term results using the Mills valvulotome. Ann Surg. 1991 ; 213 (5). 457-464 ; discussion 464-455.
10. Rafferty TD, Avellone JC, Farrell CJ, et al. A metropolitan experience with infrainguinal revascularization. Operative risk and late results in northeastern Ohio. J Vasc Surg. 1987 ; 6 (4). 365-371. (Pubitemid 17145502)
11. Quinones-Baldrich WJ, Prego AA, Ucelay-Gomez R., et al. Long-term results of infrainguinal revascularization with polytetrafluoroethylene: a ten-year experience. J Vasc Surg. 1992 ; 16 (2). 209-217.
12. Bergamini TM, Towne JB, Bandyk DF, Seabrook GR, Schmitt DD Experience with in situ saphenous vein bypasses during 1981 to 1989: determinant factors of long-term patency. J Vasc Surg. 1991 ; 13 (1). 137-147 ; ; discussion 148-139.
13. Schepers A., Klinkert P., Vrancken Peeters MP, Breslau PJ Complication registration in patients after peripheral arterial bypass surgery. Ann Vasc Surg. 2003 ; 17 (2). 198-202. (Pubitemid 36523094)
14. Hunink MG, Wong JB, Donaldson MC, Meyerovitz MF, de Vries J., Harrington DP Revascularization for femoropopliteal disease. A decision and cost-effectiveness analysis. JAMA. 1995 ; 274 (2). 165-171.
15. Romiti M., Albers M., Brochado-Neto FC, Durazzo AE, Pereira CA, De Luccia N. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg. 2008 ; 47 (5). 975-981.
16. Zhu YQ, Zhao JG, Liu F., et al. Subintimal angioplasty for below-the-ankle arterial occlusions in diabetic patients with chronic critical limb ischemia. J Endovasc Ther. 2009 ; 16 (5). 604-612.
17. Manzi M., Fusaro M., Ceccacci T., Erente G., Dalla Paola L., Brocco E. Clinical results of below-the knee intervention using pedal-plantar loop technique for the revascularization of foot arteries. J Cardiovasc Surg (Torino). 2009 ; 50 (3). 331-337.
18. Paraskevas KI, Giannoukas AD, Kotsikoris I., Mikhailidis DP Contrast-induced nephropathy and the vascular patient. Angiology. 2010 ; 61 (8). 721-723.
19. Ishibashi Y., Yamauchi M., Musha H., Mikami T., Kawasaki K., Miyake F. Impact of contrast-induced nephropathy and cardiovascular events by serum cystatin C in renal insufficiency patients undergoing cardiac catheterization. Angiology. 2010 ; 61 (8). 724-730.
20. Sadat U., Walsh SR, Norden AG, Gillard JH, Boyle JR Does oral N-acetylcysteine reduce contrast-induced renal injury in patients with peripheral arterial disease undergoing peripheral angiography? A randomized-controlled study. Angiology. 2010.
21. ACT Trial Investigators. Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy. Trials. 2009 ; 10: 38.
22. Ozhan H., Erden I., Ordu S., et al. Efficacy of short-term high-dose atorvastatin for prevention of contrast-induced nephropathy in patients undergoing coronary angiography. Angiology. 2010 ; 61 (7). 711-714.
23. Rysz J., Aronow WS, Stolarek RS, Hannam S., Mikhailidis DP, Banach M. Nephroprotective and clinical potential of statins in dialyzed patients. Expert Opin Ther Targets. 2009 ; 13 (5). 541-550.
24. Heitmeyer C., Holscher B., Fobker M., Breithardt G., Hausberg M., Reinecke H. Prognostic value of different laboratory measures of renal function for long-term mortality after contrast media-associated renal impairment. Clin Cardiol. 2010 ; 33 (12). E51 - E59.
25. Wolfe JH, Wyatt MG Critical and subcritical ischaemia. Eur J Vasc Endovasc Surg. 1997 ; 13 (6). 578-582. (Pubitemid 27332193)
26. Bradbury AW Bypass versus Angioplasty in severe ischaemia of the leg (BASIL) trial in perspective. J Vasc Surg. 2010 ; 51 (suppl5). 1S - 4S.
27. Adam DJ, Beard JD, Cleveland T., et al. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005 ; 366 (9501). 1925-1934. (Pubitemid 41713982)
28. Schwarten DE, Cutcliff WB Arterial occlusive disease below the knee: treatment with percutaneous transluminal angioplasty performed with low-profile catheters and steerable guide wires. Radiology. 1988 ; 169 (1). 71-74.
29. Brown KT, Moore ED, Getrajdman GI, Saddekni S. Infrapopliteal angioplasty: long-term follow-up. J Vasc Interv Radiol. 1993 ; 4 (1). 139-144.
30. Hanna GP, Fujise K., Kjellgren O., et al. Infrapopliteal transcatheter interventions for limb salvage in diabetic patients: importance of aggressive interventional approach and role of transcutaneous oximetry. J Am Coll Cardiol. 1997 ; 30 (3). 664-669. (Pubitemid 27397644)
31. Dorros G., Jaff MR, Murphy KJ, Mathiak L. The acute outcome of tibioperoneal vessel angioplasty in 417 cases with claudication and critical limb ischemia. Cathet Cardiovasc Diagn. 1998 ; 45 (3). 251-256. (Pubitemid 28503336)
32. Rogers JH, Laird JR Overview of new technologies for lower extremity revascularization. Circulation. 2007 ; 116 (18). 2072-2085. (Pubitemid 350027514)
33. Keeling WB, Shames ML, Stone PA, et al. Plaque excision with the Silverhawk catheter: early results in patients with claudication or critical limb ischemia. J Vasc Surg. 2007 ; 45 (1). 25-31. (Pubitemid 46043538)
34. Ramaiah V., Gammon R., Kiesz S., et al. Midterm outcomes from the TALON Registry: treating peripherals with SilverHawk: outcomes collection. J Endovasc Ther. 2006 ; 13 (5). 592-602. (Pubitemid 44749190)
35. Kandzari DE, Kiesz RS, Allie D., et al. Procedural and clinical outcomes with catheter-based plaque excision in critical limb ischemia. J Endovasc Ther. 2006 ; 13 (1). 12-22.
36. McKinsey JF, Goldstein L., Khan HU, et al. Novel treatment of patients with lower extremity ischemia: use of percutaneous atherectomy in 579 lesions. Ann Surg. 2008 ; 248 (4). 519-528.
37. Yancey AE, Minion DJ, Rodriguez C., Patterson DE, Endean ED Peripheral atherectomy in TransAtlantic InterSociety Consensus type C femoropopliteal lesions for limb salvage. J Vasc Surg. 2006 ; 44 (3). 503-509.
38. Zeller T., Rastan A., Sixt S., et al. Long-term results after directional atherectomy of femoro-popliteal lesions. J Am Coll Cardiol. 2006 ; 48 (8). 1573-1578. (Pubitemid 44528188)
39. Das TS Excimer laser-assisted angioplasty for infrainguinal artery disease. J Endovasc Ther. 2009 ; 16 (2suppl2). 1198-1104.
40. Dave RM, Patlola R., Kollmeyer K., et al. Excimer laser recanalization of femoropopliteal lesions and 1-year patency: results of the CELLO registry. J Endovasc Ther. 2009; 16 (6). 665-675.
41. Bosiers M., Peeters P., Elst FV, et al. Excimer laser assisted angioplasty for critical limb ischemia: results of the LACI Belgium Study. Eur J Vasc Endovasc Surg. 2005 ; 29 (6). 613-619. (Pubitemid 40614347)
42. Heuser RR Treatment of lower extremity vascular disease: the Diamondback 360 degrees Orbital Atherectomy System. Expert Rev Med Devices. 2008 ; 5 (3). 279-286.
43. Casserly IP Orbital atherectomy - another tool in the art of peripheral arterial intervention. Catheter Cardiovasc Interv. 2009 ; 73 (3). 413-414.
44. Korabathina R., Mody KP, Yu J., Han SY, Patel R., Staniloae CS Orbital atherectomy for symptomatic lower extremity disease. Catheter Cardiovasc Interv. 2010 ; 76 (3). 326-332.
45. Safian RD, Niazi K., Runyon JP, et al. Orbital atherectomy for infrapopliteal disease: device concept and outcome data for the OASIS trial. Catheter Cardiovasc Interv. 2009 ; 73 (3). 406-412.
46. Dattilo R. Treating calcified below-the-knee arteries. Endovascular Today. 2010 ;Spetember: 85-95.
47. Patlola R., Hebert C., Allie D. Orbital atherectomy in treatment of peripheral arterial occlusive disease below the knee: a large single-center experience. Presented at: Transcatheter Cardiovascular Therapeutics 2009; September 21 -26, 2009 ; San Francisco, CA.
48. Siablis D., Karnabatidis D., Katsanos K., et al. Infrapopliteal application of sirolimus-eluting versus bare metal stents for critical limb ischemia: analysis of long-term angiographic and clinical outcome. J Vasc Interv Radiol. 2009 ; 20 (9). 1141-1150.
49. Werk M., Langner S., Reinkensmeier B., et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation. 2008 ; 118 (13). 1358-1365.
50. Tepe G., Zeller T., Albrecht T., et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008 ; 358 (7). 689-699. (Pubitemid 351240748)
51. Feiring AJ, Krahn M., Nelson L., Wesolowski A., Eastwood D., Szabo A. Preventing leg amputations in critical limb ischemia with below-the-knee drug-eluting stents: the PaRADISE (PReventing Amputations using Drug eluting StEnts) trial. J Am Coll Cardiol. 2010 ; 55 (15). 1580-1589.
52. Makam P. BTK stenting in critical limb ischemia: a review of the data and practical techniques for below-the-knee stenting. Endovascular Today. 2010 ;September: 69-72.
53. Landini L., Leone A., Mikhailidis DP Modifying cardiovascular risk factors: newer insights and preventive measures. Curr Pharm Des. 2009 ; 15 (10). 1034-1037.
54. Smout JD, Mikhailidis DP, Shenton BK, Stansby G. Combination antiplatelet therapy in patients with peripheral vascular bypass grafts. Clin Appl Thromb Hemost. 2004 ; 10 (1). 9-18. (Pubitemid 38543712)
55. Sarigianni M., Katsiki N., Mikhailidis DP Effects of combined ezetimibe and simvastatin therapy as compared with simvastatin alone in patients with type 2 diabetes: a prospective randomized double-blind clinical trial: comment on Ruggenenti et al. Diabetes Care. 2010 ; 33: e132 ; ; author reply e133.
56. Paraskevas KI, Bessias N., Papas TT, Gekas CD, Andrikopoulos V., Mikhailidis DP Do different vascular risk factors affect all arteries equally? Angiology. 2008 ; 59 (4). 397-401.